China · Delayed Price · Currency is CNY Wuhan Hvsen Biotechnology Statistics
Total Valuation
SHE:300871 has a market cap or net worth of CNY 4.69 billion. The enterprise value is 4.59 billion.
| Market Cap | 4.69B |
| Enterprise Value | 4.59B |
Important Dates
The last earnings date was Saturday, August 15, 2026.
| Earnings Date | Aug 15, 2026 |
| Ex-Dividend Date | Jul 6, 2026 |
Share Statistics
SHE:300871 has 200.41 million shares outstanding. The number of shares has increased by 21.81% in one year.
| Current Share Class | 200.41M |
| Shares Outstanding | 200.41M |
| Shares Change (YoY) | +21.81% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 5.56% |
| Owned by Institutions (%) | 8.23% |
| Float | 105.75M |
Valuation Ratios
The trailing PE ratio is 14.30 and the forward PE ratio is 20.72.
| PE Ratio | 14.30 |
| Forward PE | 20.72 |
| PS Ratio | 2.72 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 19.32 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.44 |
| EV / Sales | 2.67 |
| EV / EBITDA | 10.61 |
| EV / EBIT | 14.87 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.20.
| Current Ratio | 2.05 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 1.07 |
| Debt / FCF | -12.55 |
| Interest Coverage | 149.17 |
Financial Efficiency
Return on equity (ROE) is 15.59% and return on invested capital (ROIC) is 13.71%.
| Return on Equity (ROE) | 15.59% |
| Return on Assets (ROA) | 6.06% |
| Return on Invested Capital (ROIC) | 13.71% |
| Return on Capital Employed (ROCE) | 11.63% |
| Weighted Average Cost of Capital (WACC) | 6.85% |
| Revenue Per Employee | 1.52M |
| Profits Per Employee | 301,619 |
| Employee Count | 1,133 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 4.23 |
Taxes
In the past 12 months, SHE:300871 has paid 46.30 million in taxes.
| Income Tax | 46.30M |
| Effective Tax Rate | 11.91% |
Stock Price Statistics
The stock price has increased by +3.08% in the last 52 weeks. The beta is 0.59, so SHE:300871's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +3.08% |
| 50-Day Moving Average | 22.62 |
| 200-Day Moving Average | 23.62 |
| Relative Strength Index (RSI) | 55.11 |
| Average Volume (20 Days) | 6,084,287 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300871 had revenue of CNY 1.72 billion and earned 341.73 million in profits. Earnings per share was 1.64.
| Revenue | 1.72B |
| Gross Profit | 600.06M |
| Operating Income | 308.93M |
| Pretax Income | 388.68M |
| Net Income | 341.73M |
| EBITDA | 433.04M |
| EBIT | 308.93M |
| Earnings Per Share (EPS) | 1.64 |
Balance Sheet
The company has 573.18 million in cash and 463.83 million in debt, with a net cash position of 109.36 million or 0.55 per share.
| Cash & Cash Equivalents | 573.18M |
| Total Debt | 463.83M |
| Net Cash | 109.36M |
| Net Cash Per Share | 0.55 |
| Equity (Book Value) | 2.33B |
| Book Value Per Share | 11.54 |
| Working Capital | 788.31M |
Cash Flow
In the last 12 months, operating cash flow was 242.87 million and capital expenditures -279.83 million, giving a free cash flow of -36.96 million.
| Operating Cash Flow | 242.87M |
| Capital Expenditures | -279.83M |
| Depreciation & Amortization | 124.12M |
| Net Borrowing | 138.70M |
| Free Cash Flow | -36.96M |
| FCF Per Share | -0.18 |
Margins
Gross margin is 34.81%, with operating and profit margins of 17.92% and 19.82%.
| Gross Margin | 34.81% |
| Operating Margin | 17.92% |
| Pretax Margin | 22.55% |
| Profit Margin | 19.82% |
| EBITDA Margin | 25.12% |
| EBIT Margin | 17.92% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 1.67%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 1.67% |
| Dividend Growth (YoY) | -3.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.00% |
| Buyback Yield | -21.81% |
| Shareholder Yield | -20.14% |
| Earnings Yield | 7.28% |
| FCF Yield | -0.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 10, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | May 10, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300871 has an Altman Z-Score of 3.96 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.96 |
| Piotroski F-Score | 6 |